3//SEC Filing
HealthCap VII, L.P. 3
Accession 0000899243-19-024764
CIK 0001781983other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:06 PM ET
Size
19.8 KB
Accession
0000899243-19-024764
Insider Transaction Report
Form 3
HealthCap VII GP S.A.
10% Owner
Holdings
- 10,559(indirect: See footnote)
Common Stock
- (indirect: See footnote)
Series C Convertible Preferred Stock
→ Common Stock (427,496 underlying) - (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (1,661,382 underlying)
HealthCap VII, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (1,661,382 underlying) - 10,559(indirect: See footnote)
Common Stock
- (indirect: See footnote)
Series C Convertible Preferred Stock
→ Common Stock (427,496 underlying)
Footnotes (2)
- [F1]The securities are directly held by HealthCap VII L.P. (the "Fund"). HealthCap VII GP S.A. (the "General Partner") is the sole general partner of the Fund. Johan Christenson has an interest in HCSA and is an employee of HealthCap VII Advisor AB. Each of the General Partner and Dr. Christenson disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner or Dr. Christenson is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- [F2]Each share of preferred stock may be converted at any time, at the option of the holder, into a share of common stock. The preferred stock will automatically convert into shares of common stock immediately prior to the closing of the Issuer's initial public offering.
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001645161
Filing Metadata
- Form type
- 3
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 7:06 PM ET
- Size
- 19.8 KB